Animal Hematology and Clinical Chemistry Analyzers and 2 Others

Open tender

Japanese title: 動物用血球計数装置および動物用臨床化学分析装置 外2件

Medical
About this page
This page is based on the official tender notice and presents information processed, translated, and edited by JBid.

Overview

Procurement of an animal hematology analyzer, an animal clinical chemistry analyzer, and two additional related items by the National Cancer Center Japan (NCC). Delivery and performance are required by March 31, 2027, at the NCC Central Hospital. The procurement is conducted by open competitive bidding with a lowest-price selection method.

Key Details

  • Source: KKJ
  • Notice type: Open tender
  • Listed on KKJ: November 13, 2026
  • Procuring entity: National Cancer Center Japan (NCC)
  • Deadline to obtain tender documents: December 7, 2026
  • Submission deadline: December 7, 2026, 17:00 JST
  • Award method: Lowest-price award
  • Eligibility (from notice): All-ministry unified qualification, 'goods manufacturing or goods sales', grade A–D, Kanto-Koshinetsu region – verify in the tender documents
  • Status: Active
  • Technology relevance: Possible
  • Business-action likelihood: Medium – The procurement is open competitive bidding with clear qualification criteria, but local after-sales service and maintenance capabilities are required, which may necessitate a local partner.

Official Notice

Official Source

KKJ, Japan's Government Procurement Information Website, which aggregates procurement notices from national and local public-sector organizations.

  • Source: KKJ (Government Procurement Information Website)
  • Official category: Open competitive tender
  • Listed on KKJ: November 13, 2026
  • Publication: Official notice document (PDF)

Full English Translation

The following English translation was prepared from the original Japanese notice published by the procuring entity and listed on KKJ, Japan's Government Procurement Information Website. The translation below is based on the Japanese source text.

Bid Announcement
November 13, 2026
The following is subject to open competitive bidding.
National Cancer Center Japan (NCC)
Director General Hiroyuki Mano
1. Items subject to competitive bidding
(1) Procurement subject and quantity
Animal hematology analyzer and animal clinical chemistry analyzer and
2 others
(2) Characteristics of procurement subject
According to the bidding documents and specifications
(3) Delivery deadline or performance period
By March 31, 2027, from contract signing date
(4) Delivery or performance location
National Cancer Center Japan Central Hospital
(5) Bidding method
The first negotiation right holder will be decided by the lowest price bid method, so:
① The bid submitted by bidders shall include all direct expenses related to the procurement subject, including equipment, materials, machinery, transportation costs, and all other expenses required for the commissioned work, and estimate the contract amount.
② In deciding the first negotiation right holder, the bid amount plus 10% of that amount (fractions less than 1 yen are rounded down) will be considered the winning bid amount; bidders must submit a bid amount corresponding to 100/110 of the estimated contract amount regardless of consumption tax status, except when the consumption tax rate differs.
③ This competition is conducted by bid classification; each bid must state the amount excluding tax.
2. Qualifications required for participants
(1) Those who fall under the provisions of Articles 6 and 7 of the NCC Contract Handling Regulations cannot participate.
(2) Those who have submitted false information or whose management or credit status has severely deteriorated may be excluded.
(3) Those qualified with grade A, B, C, or D in "manufacture" or "sale" of goods under the unified qualification notification and having competition qualification in the Kanto-Koshinetsu region.
(4) Must prove a system for prompt after-sales service and maintenance related to the purchased goods; this does not apply to service provision.
3. Location and period for contract terms and bidding document distribution
Location: Procurement Section, Finance and Accounting Department, NCC Tsukiji Campus, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045
Distribution period: November 13 to December 7, 2026 (weekdays 8:30–17:00)
Bid submission deadline: December 7, 2026, 17:00 (must arrive by then)
4. Location and date of bid opening
Location: 4th Meeting Room, 1st Floor, Management Building, NCC, 5-1-1 Tsukiji, Chuo-ku, Tokyo
Date: December 14, 2026, 14:30
5. Other matters
(1) Language and currency for contract procedures: Japanese and Japanese yen
(2) Invalid bids: Bids from unqualified participants or those who fail to fulfill obligations will be invalid.
(3) Contract document creation: Required
(4) Method of contractor decision: The bidder who meets all qualifications and requirements and submits the lowest price bid within the estimated price range will be the first negotiation right holder and contract negotiation partner.
(5) Details are according to the bidding documents.
[Contact]
Procurement Section 1, Finance and Accounting Department, NCC Tsukiji Campus
Nakagawa
Phone: 03-3547-5201 ext. 3743
Inquiry form: https://forms.cloud.microsoft/r/nzfNaUvuxT
Inquiries limited to matters related to this announcement.
Show original Japanese notice

入 札 公 告

令和8年11月13日次のとおり一般競争に付す。国立研究開発法人国立がん研究センター理事長 間野 博行1 競争入札に付する事項(1)調達件名及び数量動物用血球計数装置および動物用臨床化学分析装置外2件(2)調達件名の特質等入札説明書及び仕様書による(3)納入期限又は履行期間契約締結日から令和9年3月31日まで(4)納入場所又は履行場所国立がん研究センター中央病院(5)入札方法第一交渉権者の決定は、最低価格落札方式をもって行うので、①入札者が提出する入札書は、調達件名にかかる直接経費の他、機材、資材、機械器具、運搬費等、業務委託に要する一切の諸経費を含め、契約金額を見積もるものとする。②第一交渉権者決定にあたっては、入札書に記載された金額に当該金額の10%に相当する額を加算した金額(当該金額に1円未満の端数がある場合は、その端数金額を切り捨てた金額とする。)をもって落札金額とするので、入札者は、消費税及び地方消費税に係る課税事業者であるか免税事業者であるかを問わず、見積もった契約金額の110分の100に相当する金額を記載した入札書を提出しなければならない。※前記の消費税率とならない場合を除く③本競争は入札書の分類毎に行う。入札書にはそれぞれの金額(税抜)を記載すること。2 競争に参加する者に必要な資格に関する事項(1)国立研究開発法人国立がん研究センター契約事務取扱細則第6条及び7条に規定される各事項に該当される者は、競争に参加できない。(2)次の事項に該当する者は、競争に参加させないことがある。①資格審査申請書又は添付書類に虚偽の事実を記載した者②経営の状況又は信用度が極度に悪化している者(3)資格審査結果通知書(全省庁統一資格)において、「物品の製造」又は「物品の販売」のうちA,B,C又はDの等級に格付けされ、関東甲信越地域の競争資格を有する者。(4)購入物品等に係る迅速なアフターサービス・メンテナンス等の体制が整備されていることを証明したものであること。但し、役務の提供等については、この限りではない3 契約条項を示す場所及び期間契約条項を示す場所、入札説明書の交付場所、入札書の提出場所は、次のとおりとする〒104-0045 東京都中央区築地5-1-1国立がん研究センター財務経理部(築地キャンパス)調達課入札説明書等交付期間令和8年11月13日から令和8年12月7日まで(平日:午前8時30分から午後5時まで)入札書受領期限令和8年12月7日 午後5時(必着)4 競争執行の場所及び日時場所:東京都中央区築地5-1-1国立がん研究センター管理棟1階第四会議室日時:令和8年12月14日(月) 午後2時30分5 その他の事項(1)契約手続において使用する言語及び通貨日本語及び日本国通貨とする。(2)入札の無効本公告に示した競争参加資格のない者の提出した入札書、入札者に求められる義務を履行しなかった者の提出した入札書は無効とする。(3)契約書作成の要否要(4)契約者の決定方法本公告及び入札説明書に従い、書類・資料を添付した入札書を提出した入札者であって、本入札公告及び入札説明書の競争参加資格及び仕様書の要求、要件を全て満たし当該入札者の入札書が国立がん研究センター契約事務取扱細則第37条、38条の規定に基づいて作成された予定価格の制限の範囲内であり、かつ、最低価格をもって入札を行った者を第一交渉権者とし、契約交渉の相手方とする。(5)その他詳細は入札説明書による。【照会先】国立がん研究センター財務経理部(築地キャンパス)調達課調達第一係中川電話03-3547-5201(内線3743)問い合わせフォーム: https://forms.cloud.microsoft/r/nzfNaUvuxTなお、照会内容は本公告に係る事項のみとする。

Business Signal

Business Relevance

Potential relevance requires a targeted fit check. Confirm the supplier's documented capabilities against the actual requirements and verify a participation route.

  • Product fit: Potential
  • Current-case feasibility: Unknown
  • Evidence confidence: Low
  • Supply-chain security: Unknown

Earliest required deadline in the examined route (Japan time): 2026-12-07T17:00:00+09:00

Participation fit

Participation is expected to require appropriate Japanese government procurement eligibility, or cooperation with a suitable Japanese partner holding the required qualification. The eligibility requirements have not been fully reviewed and should be verified against the official tender documents.

JBid analysis. Interpretations and questions below do not establish procurement requirements; consult the official documents for those requirements.

This page is based on the official procurement notice published by the procuring entity and listed on KKJ, Japan's Government Procurement Information Website, with translation and a preliminary business assessment by I.J. Do. The official Japanese notice and tender documents are binding.

JBid is a beta technology-procurement intelligence service by I.J. Do.

Back to daily list